We recruit motivated and committed undergraduated or graduated students whose interest is doing their master or PhD in our research labs.
CCUL is affiliated with the Academic Medical Center of Lisbon (CAML) and most of the PhD students integrate the Doctoral Programme of the CAML. CAML’s research-oriented PhD Programme aims at encouraging clinicians to formulate new questions regarding patients and diseases and bring them to the laboratory. And, conversely, bring questions from the lab to clinical practice. By bringing together medical and non-medical researchers, the program fosters new collaborative approaches and a more effective communication between basic and clinical researchers. For more information click HERE
BIOMEDICAL RESEARCH MASTER
A multidisciplinary, transversal and integrated Master training from the bench to the bedside grounded on the major areas of biomedical research, including Cardiovascular Biology.
The students have the opportunity to pursue their research projects within the Lisbon Academic Medical Centre environment with top scientists and a vibrant atmosphere, obtaining state-of-the-art biomedical training in our unique setting combining the Hospital, Medical School and Research Institutes, where teams of researchers are working together.
Scientific Committee: Luís Graça (FMUL)
Coordinators of the Cardiovascular Biology Curricular Unit: Fausto Pinto (CCUL, FMUL); Susana Constantino (CCUL, FMUL)
For more information please click HERE.
CARDIOVASCULAR IMAGING MASTER
Cardiovascular Imaging is a key medical area for the establishment of diagnosis, risk stratification and clinical, therapeutic, monitoring, prognosis in Cardiovascular Medicine. The technological evolution of cardiovascular imaging, in the last decades, combined with its exponential clinical application, has led to the need for its in-depth knowledge by clinicians and stimulated a strong interest both in basic research by engineers and physicists, both in clinical and translational research.
CARDIO-ONCOLOGY POST-GRADUATED COURSE
Cardio-oncology is a fast growing field that has great importance as newly developed cancer treatment improve cancer survival. With innovative treatments, come new or unexpected cardiovascular toxicities as many cancer survivors are now living enough to experience the potential cardiotoxic effects of these treatments.
NEW FRONTIERS IN CARDIOMYOPATHIES
Cardiomyopathies are complex diseases. Knowledge has been growing in the last decades, in part due to the enormous advances in imaging and genetics. These conditions are expressed by varied cardiac phenotypes, sometimes overlapping or mixed, and are a frequent cause of heart failure, arrhythmias, and sudden death. Cardiomyopathies are difficult to diagnose and often have a genetic cause. Due to their complexity and heterogeneity these conditions require clinical knowledge in several medical domains. They are a cutting-edge area in terms of molecular and pathophysiological research, with some entities fitting ideal translational models. The knowledge of cardiomyopathies regarding the mechanisms involved in their development and progression is increasing, as are the diagnostic meth
ods and new therapeutic agents able to control the natural history of these diseases, or even to prevent disease development. It
is challenging to keep updated in the continuous evolution of the knowledge in this field. How to diagnose and manage, how to choose the best candidates for new or specific therapies, how to follow patients and their affected relatives, these are some of the educational needs regarding the clinical approach of patients with cardiomyopathies, which are frequently stated by cardiologists and internal medicine specialists. This LEE aims to provide up-to-date knowledge and practical training in the field.
Medical specialists, in particular cardiologists and internal medicine specialists.
For more information click HERE
NEW FRONTIERS IN CARDIOVASCULAR MEDICINE – PULMONARY HYPERTENSION
Pulmonary hypertension (PH) is a common and widely under-recognised hemodynamic condition that results from a surprisingly large number of disease processes. All age groups are affected with rapidly growing importance in elderly people, particularly in countries with ageing populations. In recent years we have come a long way in our understanding of PH. As a result of ever-increasing experience in treating pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH), and the availability of new treatment options, there have been continual improvements in patient outcomes.
Our University Hospital integrates a national expert referral PH centre that provides care by a multiprofessional team with experience in pulmonary circulation and right heart failure, enabling the organization of a postgraduate course on PH. Clinical experts are invited to present an up-to-date overview on cutting edge PH therapies and best practice strategies in the evaluation and management of pulmonary vascular disease from early diagnosis, risk stratification and long-term surveillance.
This postgraduate course is intended for cardiologists, pulmonologists, internists, rheumatologists and other affiliated healthcare professionals who are involved in the care of PH patients or have a special interest in this area.
Educational Objectives: Describe the epidemiology and pathophysiology of PH; Determine who is at risk for PH; Correct clinical and hemodynamic diagnosis of PH; Recognize the difference between PAH and other PH forms; Evaluate current pharmacologic and percutaneous/surgical management strategies for patients with PH; Outline the current approach to PH treatment in the presence of comorbidities; Incorporate novel therapies into patient care for improved outcomes.
Chairman: Prof. Fausto Pinto (FMUL); Co-Chairman: Dr Nuno Lousada; Course Director: Dr Rui Plácido
For more information please click HERE.
NEW FRONTIERS IN CARDIOLOGY – FOCUS ON CTO
As CTO become an important procedure to treat symptomatic patients with ischemia or heart failure and with constant novelties that improve the technic and when well used boosts the quality of the healthcare professional. It is important for a hospital department that all the news novelties can be discussed at the national and international level hearing the best national and international researchers and professionals in the area.
So, this course has as an important role in updating the national and international healthcare professionals on the recent advances in CTO.
Scientific Committee: Prof. Fausto Pinto (FMUL); Pedro Canas (CHULN-HSM); Pedro Pinto Cardoso (CHULN-HSM); Pedro Canas (CHULN-HSM); Pedro Pinto Cardoso (CHULN-HSM)
For more information please click HERE.
Running clinical studies is a complex task that requires many skills ranging from Good Clinical Practice knowledge of applicable regulations up to operational aspects on how to carry out clinical studies. Having a high trained and specialized study team conducting clinical research is the main key to achieve success in recruitment objectives and high standards of quality and performance.
This course is organized in collaboration with the GAIC and CCUL.
With focus on the practical aspects of clinical studies, the course has the main objectives:
- Provide to the participants the tools and knowledge needed to successfully achieve quality and high performance in all steps of clinical research.
- Provide information on clinical research practical aspects, essential to achieve the highest quality data, ensuring the safety and well-being of study participants.
- Identify all the parties involved in a clinical trial and the main responsibilities associated with each of them (e.g. Sponsor, Principal Investigator, CRO, and Monitor).
- Understand the roles and responsibilities of the different parties involved in a clinical research, and the fundamentals of Good Clinical Practice (GCP).
- Understand the current legislation, National and European, and other standards of reference applicable to clinical research.
- Identify the responsible authorities for approving a clinical trial, their respective timelines for approval, and the documents required for submitting an application for a clinical trial authorization.
- Understand which the regulatory activities are after the clinical trial approval.
- Describe the different types of clinical research with emphasis on clinical trials and their phases.
- Understand the difference between Quality control vs. Quality assurance and Audits vs. Inspections
Inês Zimbarra Cabrita
Francisca Patuleia Figueiras
For more information cick HERE